Frontlight ResearchEarly access
Trial site
National Cheng Kung University Hospitalx
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Ovarian cancer1 trial
- and 1 more
- Phase
- Phase 32 trials
- Phase 1/21 trial
- Status
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Daiichi Sankyo3 trials
Running trials
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026